Brief: Interpace Announces Extension Of Labcorp Agreement
Feb 24 (Reuters) - Interpace Biosciences Inc IDXG.O :
* INTERPACE ANNOUNCES EXTENSION OF LABCORP AGREEMENT
* INTERPACE BIOSCIENCES - AGREEMENT WITH LABCORP HAS BEEN
EXTENDED
FOR ADDITIONAL 2 YRS, THROUGH JAN. 2022
* INTERPACE BIOSCIENCES - TERMS OF AGREEMENT EXTENSION WERE
NOT
DISCLOSED
Source text for Eikon: ID:nGNX9gvXtQ
Further company coverage: IDXG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million